Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977

Classical and alternative complement pathway activation by pneumococci.

C G Stephens, R C Williams Jr, W P Reed
PMCID: PMC421118  PMID: 19357

Abstract

Sixty-two strains of Streptococcus pneumoniae were studied for their abilities to consume selected components of classical and alternative complement pathways in human sera. The classical pathway was blocked by chelating calcium with ethyleneglycol-bios (beta-aminoethyl ether)-N,N-tetraacetic acid and by removing C4. The alternative pathway was blocked by removing factor B. Each strain's activation of the two pathways was compared with its nonimmune reactivity with the Fc region of immunoglobulin G (IgG). Activation of the classical complement pathway appeared to be independent of such Fc reactivity. Highly Fc-reactive strains, however, were shown to activate the alternative pathway more effectively than did less Fc-reactive strains. Since pneumococcal activation of the alternative pathway requires non-immunospecific IgG, these findings suggest that nonimmune binding of IgG on the pneumococcal surface endows it with complement-activating properties.

Full text

PDF
296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Pelger R. J. Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination. Appl Microbiol. 1972 Nov;24(5):679–683. doi: 10.1128/am.24.5.679-683.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Austrian R. Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus. J Infect Dis. 1975 Apr;131(4):474–484. doi: 10.1093/infdis/131.4.474. [DOI] [PubMed] [Google Scholar]
  3. Coonrod J. D., Leach R. P. Antigenemia in fulminant pneumococcemia. Ann Intern Med. 1976 May;84(5):561–563. doi: 10.7326/0003-4819-84-5-561. [DOI] [PubMed] [Google Scholar]
  4. Ishizaka T., Soto C. S., Ishizaka K. Characteristics of complement fixation by aggregated IgE. J Immunol. 1972 Dec;109(6):1290–1295. [PubMed] [Google Scholar]
  5. Johnson B. J., Thames K. E. Investigations of the complement-fixing sites of immunoglobulins. J Immunol. 1976 Nov;117(5 Pt 1):1491–1494. [PubMed] [Google Scholar]
  6. Johnston R. B., Jr, Klemperer M. R., Alper C. A., Rosen F. S. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med. 1969 Jun 1;129(6):1275–1290. doi: 10.1084/jem.129.6.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kehoe J. M., Fougereau M. Immunoglobulin peptide with complement fixing activity. Nature. 1969 Dec 20;224(5225):1212–1213. doi: 10.1038/2241212a0. [DOI] [PubMed] [Google Scholar]
  8. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  9. McLean R. H., Michael A. F. Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis. J Clin Invest. 1973 Mar;52(3):634–644. doi: 10.1172/JCI107225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Medicus R. G., Götze O., Müller-Eberhard H. J. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med. 1976 Oct 1;144(4):1076–1093. doi: 10.1084/jem.144.4.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nicholson A., Brade V., Lee G. D., Shin H. S., Mayer M. M. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly. J Immunol. 1974 Mar;112(3):1115–1123. [PubMed] [Google Scholar]
  12. PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
  13. Palmer J. W. A SIMPLE METHOD FOR PREPARING ANTIGENIC SUBSTANCES FROM THE TYPHOID BACILLUS. Science. 1940 Aug 16;92(2381):155–156. doi: 10.1126/science.92.2381.155. [DOI] [PubMed] [Google Scholar]
  14. Reed W. P., Albright E. L. Serum factors responsible for killing of Shigella. Immunology. 1974 Jan;26(1):205–215. [PMC free article] [PubMed] [Google Scholar]
  15. Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Root R. K., Ellman L., Frank M. M. Bactericidal and opsonic properties of C4-deficient guinea pig serum. J Immunol. 1972 Sep;109(3):477–486. [PubMed] [Google Scholar]
  17. Rutstein D. D., Walker W. H. COMPLEMENT ACTIVITY IN PNEUMONIA. J Clin Invest. 1942 May;21(3):347–352. doi: 10.1172/JCI101308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rytel M. W., Dee T. H., Ferstenfeld J. E., Hensley G. T. Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC). Am J Med. 1974 Dec;57(6):889–896. doi: 10.1016/0002-9343(74)90166-1. [DOI] [PubMed] [Google Scholar]
  19. Sandberg A. L., Osler A. G. Dual pathways of complement interaction with guinea pig immunoglobulins. J Immunol. 1971 Nov;107(5):1268–1273. [PubMed] [Google Scholar]
  20. Stephens C. G., Reed W. P., Kronvall G., Williams R. C., Jr Reactions between certain strains of pneumococci and Fc of IgG. J Immunol. 1974 Jun;112(6):1955–1960. [PubMed] [Google Scholar]
  21. Stålenheim G., Götze O., Cooper N. R., Sjöquist J., Müller-Eberhard H. J. Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus. Immunochemistry. 1973 Aug;10(8):501–507. doi: 10.1016/0019-2791(73)90221-8. [DOI] [PubMed] [Google Scholar]
  22. Winkelstein J. A., Shin H. S. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J Immunol. 1974 May;112(5):1635–1642. [PubMed] [Google Scholar]
  23. Winkelstein J. A., Shin H. S., Wood W. B., Jr Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol. 1972 Jun;108(6):1681–1689. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES